Seer Inc. (SEER): Net earnings per share (EPS TTM)

Seer, Inc. (SEER) - corporate logo

Patents for unique nanotechnologies create a powerful defensive moat for Seer, Inc. (SEER) against competitors. An impeccable reputation within the scientific community confirms the precision of the company's solutions. However, the struggle for laboratory budgets against industry behemoths remains intense. The rolling net income per share trend captures current dynamics, where the metric holds around -1.14, helping investors assess valuation risks.

Seer, Inc. (SEER) - Earnings per share for the trailing year from 07/04/2022 to 11/14/2026

Analytical breakdowns and data insights for company Seer Inc. (SEER)

- stock price and consensus target price:
Stock Price Seer Inc|SEER - Analyst Median Target
- stock exchange capitalization data:
Market Capitalization Seer Bio|SEER - Real Price to Acquire Entire Company
- business book valuation details:
Accounting Value per Share Seer|SEER - Accounting Value of Company|Market Value to Book Value Ratio seer.bio|SEER - Cumulative Company Assets
- debt and liquidity data:
Total Debt to Capital Seer, Inc.|SEER - Long-Term Liabilities to Capital|Short-Term Debt to Capital Seer|SEER - Company Aggregate Debt|Debts to Book Capitalization Seer|SEER - Long-Term Debt Volume|Company Short-Term Debts Seer|Quick Ratio seer.bio
- earnings and valuation multiples indicators:
SEER - Net Profit|Expected Profit Seer, Inc.|SEER - Price to Earnings Ratio|Projected Price to Earnings Seer Inc.|SEER - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Seer, Inc.|SEER - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Seer|SEER - Net earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months seer.bio|SEER - Earnings growth in current year|Earnings growth forecast for next year Seer, Inc.
- issuer revenue and sales details:
SEER - Company Gross Revenue|Company Projected Revenue Seer, Inc.|SEER - Price-to-Sales Ratio|Price-to-Projected Revenue Ratio Seer Bio
Fundamental valuation:Seer Inc (SEER)
Manufactured products of Seer Inc

Seer, Inc. leadership in the proteomics sector requires high capital intensity, meaning that calculating annual net income per share allows for an assessment of the actual monetization efficiency of its visionary developments in personalized medicine. By analyzing a snapshot of the rolling annual revenue per share, an investor filters out temporary market noise to determine the fundamental stability of the business and the degree of capital protection against volatility.

Competitors of Seer, Inc.

Abbott Labs - Net earnings per share (EPS TTM)|Thermo Fisher Corp (TMO) - Net earnings per share for the last 12 months|GEHC: Net earnings per share (EPS TTM)|Mettler Toledo Inc - Earnings per share for the trailing year|Earnings per share for the last twelve months waters.com|TECH: Earnings per share for the trailing year|Earnings per share for the last twelve months Bruker Corp (BRKR)|Net earnings per share for the last 12 months Azenta AZTA|Net earnings per share (EPS TTM) VREX (vareximaging.com)|Semler Scientific Corp (SMLR) - Net earnings per one share for the last twelve months|Butterfly Network - Net earnings per share (EPS TTM)|MLAB (Mesa Laboratories, Inc.) - Earnings per share for the last 12 months|QSI: Net earnings per share (EPS TTM)|NNOX - Net earnings per share for the last four quarters|QTRX (Quanterix Inc) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months 908 Devices Corp (MASS)|Net earnings per share for the last 12 months CV (CapsoVision, Inc.)|Net earnings per share (EPS TTM) maxcyte.com (MXCT)|Earnings per share for the last twelve months Rapid Micro RPID|Hyperfine Corp - Earnings per share for the last twelve months|FONR: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months Daxor|MDAI: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months VivoSim Labs Inc (VIVS)|Earnings per share for the last twelve months aclarion.com|AKYA - Net earnings per share for the trailing year|Net earnings per share for the last 12 months THMO (ThermoGenesis Holdings, Inc.)|Net earnings per share (EPS TTM) Talis Biomedical Corporation (TLIS)|Net earnings per share (EPS TTM) TTOO (t2biosystems.com)